DCCR Cancer Information Systems Program Renewed For Three More Years; Two Dropped, Two Added
In Brief: Hew Approves Patent Request From U. Arizona; Califano Still Pondering Bioassay Program Fate
Flexibility OK In Paying Grants If Justified, Upton Affirms
Gori to Hopkins Part Time, Keeps DCCP Deputy Job
DCCP To Have Board Of Scientific Counselors
Clearinghouse Finds Seven Compounds Are Carcinogenic, Human Threat
Eleven Chemicals Rated for Tests


Trending Stories
- Brawley: ACS prostate cancer screening guideline should say no to “mass screening”
- NCI’s Letai, FDA’s Diamantas identify strategies to speed up cancer trials
Letai: 150 days to start a cancer trial is too long—cancer centers need to accept a little risk - ACS strengthens recommendation for prostate cancer screening
Many will hear the endorsement and ignore the limitations - Kay “Taddy” Dickersin, NBCC co-founder, dies at 74
- CMS rule cuts overall oncology payments by estimated 2%
Final rule slashes 340B, moves toward site-neutrality - In the 90s, Barry Kramer persuaded NCI to get out of the business of screening guidelines
At the time, USPSTF was better equipped to do the job. Is it still?









